[go: up one dir, main page]

SG10202000486VA - Systems and methods to detect rare mutations and copy number variation - Google Patents

Systems and methods to detect rare mutations and copy number variation

Info

Publication number
SG10202000486VA
SG10202000486VA SG10202000486VA SG10202000486VA SG10202000486VA SG 10202000486V A SG10202000486V A SG 10202000486VA SG 10202000486V A SG10202000486V A SG 10202000486VA SG 10202000486V A SG10202000486V A SG 10202000486VA SG 10202000486V A SG10202000486V A SG 10202000486VA
Authority
SG
Singapore
Prior art keywords
systems
methods
copy number
number variation
rare mutations
Prior art date
Application number
SG10202000486VA
Inventor
Amirali Talasaz
Helmy Eltoukhy
Original Assignee
Guardant Health Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=50237580&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG10202000486V(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Guardant Health Inc filed Critical Guardant Health Inc
Publication of SG10202000486VA publication Critical patent/SG10202000486VA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869—Methods for sequencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1065—Preparation or screening of tagged libraries, e.g. tagged microorganisms by STM-mutagenesis, tagged polynucleotides, gene tags
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869—Methods for sequencing
    • C12Q1/6874—Methods for sequencing involving nucleic acid arrays, e.g. sequencing by hybridisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
    • G16B30/10—Sequence alignment; Homology search
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2537/00—Reactions characterised by the reaction format or use of a specific feature
    • C12Q2537/10—Reactions characterised by the reaction format or use of a specific feature the purpose or use of
    • C12Q2537/165—Mathematical modelling, e.g. logarithm, ratio
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2545/00—Reactions characterised by their quantitative nature
    • C12Q2545/10—Reactions characterised by their quantitative nature the purpose being quantitative analysis
    • C12Q2545/114—Reactions characterised by their quantitative nature the purpose being quantitative analysis involving a quantitation step
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Pathology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Theoretical Computer Science (AREA)
  • Evolutionary Biology (AREA)
  • Medical Informatics (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plant Pathology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Silver Salt Photography Or Processing Solution Therefor (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Indexing, Searching, Synchronizing, And The Amount Of Synchronization Travel Of Record Carriers (AREA)
SG10202000486VA 2012-09-04 2013-09-04 Systems and methods to detect rare mutations and copy number variation SG10202000486VA (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201261696734P 2012-09-04 2012-09-04
US201261704400P 2012-09-21 2012-09-21
US201361793997P 2013-03-15 2013-03-15
US201361845987P 2013-07-13 2013-07-13

Publications (1)

Publication Number Publication Date
SG10202000486VA true SG10202000486VA (en) 2020-03-30

Family

ID=50237580

Family Applications (2)

Application Number Title Priority Date Filing Date
SG10202000486VA SG10202000486VA (en) 2012-09-04 2013-09-04 Systems and methods to detect rare mutations and copy number variation
SG11201501662TA SG11201501662TA (en) 2012-09-04 2013-09-04 Systems and methods to detect rare mutations and copy number variation

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG11201501662TA SG11201501662TA (en) 2012-09-04 2013-09-04 Systems and methods to detect rare mutations and copy number variation

Country Status (16)

Country Link
US (29) US10041127B2 (en)
EP (6) EP3842551B1 (en)
JP (6) JP6275145B2 (en)
KR (5) KR20240007774A (en)
CN (2) CN110872617A (en)
CA (2) CA2883901C (en)
DE (1) DE202013012824U1 (en)
DK (1) DK2893040T5 (en)
ES (5) ES2711635T3 (en)
GB (1) GB2533006B (en)
IL (3) IL269097B2 (en)
MX (1) MX367963B (en)
PL (2) PL2893040T3 (en)
PT (1) PT2893040T (en)
SG (2) SG10202000486VA (en)
WO (1) WO2014039556A1 (en)

Families Citing this family (343)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11111543B2 (en) 2005-07-29 2021-09-07 Natera, Inc. System and method for cleaning noisy genetic data and determining chromosome copy number
US9424392B2 (en) 2005-11-26 2016-08-23 Natera, Inc. System and method for cleaning noisy genetic data from target individuals using genetic data from genetically related individuals
US11111544B2 (en) * 2005-07-29 2021-09-07 Natera, Inc. System and method for cleaning noisy genetic data and determining chromosome copy number
US10083273B2 (en) 2005-07-29 2018-09-25 Natera, Inc. System and method for cleaning noisy genetic data and determining chromosome copy number
US10081839B2 (en) 2005-07-29 2018-09-25 Natera, Inc System and method for cleaning noisy genetic data and determining chromosome copy number
ES2640776T3 (en) 2009-09-30 2017-11-06 Natera, Inc. Methods for non-invasively calling prenatal ploidy
US11939634B2 (en) 2010-05-18 2024-03-26 Natera, Inc. Methods for simultaneous amplification of target loci
US11339429B2 (en) 2010-05-18 2022-05-24 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US9677118B2 (en) 2014-04-21 2017-06-13 Natera, Inc. Methods for simultaneous amplification of target loci
US10316362B2 (en) 2010-05-18 2019-06-11 Natera, Inc. Methods for simultaneous amplification of target loci
US11322224B2 (en) 2010-05-18 2022-05-03 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US11408031B2 (en) 2010-05-18 2022-08-09 Natera, Inc. Methods for non-invasive prenatal paternity testing
US11326208B2 (en) 2010-05-18 2022-05-10 Natera, Inc. Methods for nested PCR amplification of cell-free DNA
US11332793B2 (en) 2010-05-18 2022-05-17 Natera, Inc. Methods for simultaneous amplification of target loci
US12221653B2 (en) 2010-05-18 2025-02-11 Natera, Inc. Methods for simultaneous amplification of target loci
EP2854058A3 (en) 2010-05-18 2015-10-28 Natera, Inc. Methods for non-invasive pre-natal ploidy calling
US12152275B2 (en) 2010-05-18 2024-11-26 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US11332785B2 (en) 2010-05-18 2022-05-17 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US20190010543A1 (en) 2010-05-18 2019-01-10 Natera, Inc. Methods for simultaneous amplification of target loci
US8361720B2 (en) 2010-11-15 2013-01-29 Exact Sciences Corporation Real time cleavage assay
US8916344B2 (en) 2010-11-15 2014-12-23 Exact Sciences Corporation Methylation assay
RU2620959C2 (en) 2010-12-22 2017-05-30 Натера, Инк. Methods of noninvasive prenatal paternity determination
KR20210131432A (en) 2010-12-30 2021-11-02 파운데이션 메디신 인코포레이티드 Optimization of multigene analysis of tumor samples
CA2824387C (en) 2011-02-09 2019-09-24 Natera, Inc. Methods for non-invasive prenatal ploidy calling
WO2012129363A2 (en) 2011-03-24 2012-09-27 President And Fellows Of Harvard College Single cell nucleic acid detection and analysis
DK3246416T3 (en) 2011-04-15 2024-09-02 Univ Johns Hopkins SECURE SEQUENCE SYSTEM
WO2012177792A2 (en) 2011-06-24 2012-12-27 Sequenom, Inc. Methods and processes for non-invasive assessment of a genetic variation
US20130079241A1 (en) 2011-09-15 2013-03-28 Jianhua Luo Methods for Diagnosing Prostate Cancer and Predicting Prostate Cancer Relapse
US10424394B2 (en) 2011-10-06 2019-09-24 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
US9367663B2 (en) 2011-10-06 2016-06-14 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
CA2850785C (en) 2011-10-06 2022-12-13 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
US9984198B2 (en) 2011-10-06 2018-05-29 Sequenom, Inc. Reducing sequence read count error in assessment of complex genetic variations
US10196681B2 (en) 2011-10-06 2019-02-05 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
JP6431769B2 (en) 2012-01-20 2018-11-28 セクエノム， インコーポレイテッド Diagnostic process including experimental conditions as factors
HUE053360T2 (en) 2012-02-17 2021-06-28 Hutchinson Fred Cancer Res Compositions and methods for accurate identification of mutations
US9892230B2 (en) 2012-03-08 2018-02-13 The Chinese University Of Hong Kong Size-based analysis of fetal or tumor DNA fraction in plasma
DK2828218T3 (en) 2012-03-20 2020-11-02 Univ Washington Through Its Center For Commercialization METHODS OF LOWERING THE ERROR RATE OF MASSIVELY PARALLEL DNA SEQUENCING USING DUPLEX CONSENSUS SEQUENCING
CN104428425A (en) * 2012-05-04 2015-03-18 考利达基因组股份有限公司 Methods for determining absolute genome-wide copy number variations of complex tumors
US10504613B2 (en) 2012-12-20 2019-12-10 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
US9920361B2 (en) 2012-05-21 2018-03-20 Sequenom, Inc. Methods and compositions for analyzing nucleic acid
US11261494B2 (en) 2012-06-21 2022-03-01 The Chinese University Of Hong Kong Method of measuring a fractional concentration of tumor DNA
US10497461B2 (en) 2012-06-22 2019-12-03 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
US20150011396A1 (en) 2012-07-09 2015-01-08 Benjamin G. Schroeder Methods for creating directional bisulfite-converted nucleic acid libraries for next generation sequencing
US20140100126A1 (en) 2012-08-17 2014-04-10 Natera, Inc. Method for Non-Invasive Prenatal Testing Using Parental Mosaicism Data
US20160040229A1 (en) 2013-08-16 2016-02-11 Guardant Health, Inc. Systems and methods to detect rare mutations and copy number variation
US10876152B2 (en) 2012-09-04 2020-12-29 Guardant Health, Inc. Systems and methods to detect rare mutations and copy number variation
US11913065B2 (en) 2012-09-04 2024-02-27 Guardent Health, Inc. Systems and methods to detect rare mutations and copy number variation
DK2893040T5 (en) 2012-09-04 2019-03-18 Guardant Health Inc METHODS TO DETECT RARE MUTATIONS AND CAPITAL VARIATION
US10482994B2 (en) 2012-10-04 2019-11-19 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
CA2889937C (en) 2012-10-29 2020-12-29 The Johns Hopkins University Papanicolaou test for ovarian and endometrial cancers
US9218450B2 (en) * 2012-11-29 2015-12-22 Roche Molecular Systems, Inc. Accurate and fast mapping of reads to genome
WO2014093330A1 (en) 2012-12-10 2014-06-19 Clearfork Bioscience, Inc. Methods for targeted genomic analysis
US20130309666A1 (en) 2013-01-25 2013-11-21 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
ES2980689T3 (en) 2013-03-15 2024-10-02 Guardant Health Inc Methods for cell-free polynucleotide sequencing
US20140274738A1 (en) 2013-03-15 2014-09-18 Nugen Technologies, Inc. Sequential sequencing
HUE061261T2 (en) 2013-04-03 2023-05-28 Sequenom Inc Methods and processes for non-invasive assessment of genetic variations
WO2014190286A2 (en) 2013-05-24 2014-11-27 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
IL283586B2 (en) 2013-06-21 2023-11-01 Sequenom Inc Methods and processes for non-invasive evaluation of genetic variations
US10577655B2 (en) 2013-09-27 2020-03-03 Natera, Inc. Cell free DNA diagnostic testing standards
US10262755B2 (en) 2014-04-21 2019-04-16 Natera, Inc. Detecting cancer mutations and aneuploidy in chromosomal segments
JP6525434B2 (en) 2013-10-04 2019-06-05 セクエノム， インコーポレイテッド Methods and processes for non-invasive assessment of gene mutations
EP3851539A1 (en) 2013-10-07 2021-07-21 Sequenom, Inc. Methods and processes for non-invasive assessment of chromosome alterations
KR102429186B1 (en) 2013-10-21 2022-08-03 베리나타 헬스, 인코포레이티드 Method for improving the sensitivity of detection in determining copy number variations
US10450620B2 (en) 2013-11-07 2019-10-22 The Board Of Trustees Of The Leland Stanford Junior University Cell-free nucleic acids for the analysis of the human microbiome and components thereof
JP6525473B2 (en) 2013-11-13 2019-06-05 ニューゲン テクノロジーズ， インコーポレイテッド Compositions and methods for identifying replicate sequencing leads
EP3524694B1 (en) 2013-12-28 2020-07-15 Guardant Health, Inc. Methods and systems for detecting genetic variants
ES2818625T3 (en) 2013-12-30 2021-04-13 Univ Pittsburgh Commonwealth Sys Higher Education Fusion genes associated with progressive prostate cancer
JP6659575B2 (en) 2014-04-21 2020-03-04 ナテラ， インコーポレイテッド Mutation detection and chromosomal segment ploidy
ES2844229T3 (en) 2014-05-13 2021-07-21 Univ Texas Gene mutations and copy number alterations of EGFR, KRAS, and MET
EP3149202A1 (en) * 2014-05-26 2017-04-05 Ebios Futura S.r.l. Method of prenatal diagnosis
CN106795558B (en) * 2014-05-30 2020-07-10 维里纳塔健康公司 Detection of fetal subchromosomal aneuploidy and copy number variation
EP3149640B1 (en) * 2014-05-30 2019-09-04 Sequenom, Inc. Chromosome representation determinations
US20180173845A1 (en) 2014-06-05 2018-06-21 Natera, Inc. Systems and Methods for Detection of Aneuploidy
EP3193944B1 (en) 2014-07-17 2021-04-07 University of Pittsburgh - Of the Commonwealth System of Higher Education Methods of treating cells containing fusion genes
GB201412834D0 (en) 2014-07-18 2014-09-03 Cancer Rec Tech Ltd A method for detecting a genetic variant
PT3543356T (en) 2014-07-18 2021-10-04 Univ Hong Kong Chinese Methylation pattern analysis of tissues in dna mixture
KR102696857B1 (en) 2014-07-25 2024-08-19 유니버시티 오브 워싱톤 Methods of determining tissues and/or cell types giving rise to cell-free dna, and methods of identifying a disease or disorder using same
EP3760739B1 (en) 2014-07-30 2025-09-03 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
CA2957633A1 (en) * 2014-08-06 2016-02-11 Nugen Technologies, Inc. Digital measurements from targeted sequencing
US20160053301A1 (en) 2014-08-22 2016-02-25 Clearfork Bioscience, Inc. Methods for quantitative genetic analysis of cell free dna
US10184154B2 (en) 2014-09-26 2019-01-22 Mayo Foundation For Medical Education And Research Detecting cholangiocarcinoma
CA2967447A1 (en) 2014-12-05 2016-06-09 Foundation Medicine, Inc. Multigene analysis of tumor samples
WO2016090584A1 (en) * 2014-12-10 2016-06-16 深圳华大基因研究院 Method and device for determining concentration of tumor nucleic acid
EP3567120B1 (en) * 2014-12-12 2020-08-19 Verinata Health, Inc. Using cell-free dna fragment size to determine copy number variations
WO2016095093A1 (en) * 2014-12-15 2016-06-23 天津华大基因科技有限公司 Method for screening tumor, method and device for detecting variation of target region
US9618474B2 (en) 2014-12-18 2017-04-11 Edico Genome, Inc. Graphene FET devices, systems, and methods of using the same for sequencing nucleic acids
US10006910B2 (en) 2014-12-18 2018-06-26 Agilome, Inc. Chemically-sensitive field effect transistors, systems, and methods for manufacturing and using the same
US10020300B2 (en) 2014-12-18 2018-07-10 Agilome, Inc. Graphene FET devices, systems, and methods of using the same for sequencing nucleic acids
EP3235010A4 (en) 2014-12-18 2018-08-29 Agilome, Inc. Chemically-sensitive field effect transistor
US9859394B2 (en) 2014-12-18 2018-01-02 Agilome, Inc. Graphene FET devices, systems, and methods of using the same for sequencing nucleic acids
US9857328B2 (en) 2014-12-18 2018-01-02 Agilome, Inc. Chemically-sensitive field effect transistors, systems and methods for manufacturing and using the same
CN107111693A (en) * 2014-12-29 2017-08-29 考希尔股份有限公司 Method for determining the genotype in high homology region
ES2923602T3 (en) * 2014-12-31 2022-09-28 Guardant Health Inc Detection and treatment of diseases showing cellular heterogeneity of disease and systems and methods for communicating test results
US10364467B2 (en) * 2015-01-13 2019-07-30 The Chinese University Of Hong Kong Using size and number aberrations in plasma DNA for detecting cancer
CN107771221B (en) * 2015-02-10 2021-11-02 香港中文大学 Mutation Detection for Cancer Screening and Fetal Analysis
US10435755B2 (en) 2015-03-27 2019-10-08 Exact Sciences Development Company, Llc Detecting esophageal disorders
JP6995625B2 (en) 2015-05-01 2022-01-14 ガーダント ヘルス， インコーポレイテッド Diagnostic method
DK3294906T3 (en) 2015-05-11 2024-08-05 Natera Inc Methods for determining ploidy
US10395759B2 (en) * 2015-05-18 2019-08-27 Regeneron Pharmaceuticals, Inc. Methods and systems for copy number variant detection
WO2016187234A1 (en) 2015-05-18 2016-11-24 Karius, Inc. Compositions and methods for enriching populations of nucleic acids
EP3307908B1 (en) 2015-06-09 2019-09-11 Life Technologies Corporation Methods for molecular tagging
KR101828052B1 (en) * 2015-06-24 2018-02-09 사회복지법인 삼성생명공익재단 Method and apparatus for analyzing copy-number variation (cnv) of gene
GB201819855D0 (en) * 2015-07-07 2019-01-23 Farsight Genome Systems Inc Methods and systems for sequencing-based variant detection
US20180211002A1 (en) * 2015-07-13 2018-07-26 Agilent Technologies Belgium Nv System and methodology for the analysis of genomic data obtained from a subject
WO2017015513A1 (en) 2015-07-21 2017-01-26 Guardant Health, Inc. Locked nucleic acids for capturing fusion genes
HUE064231T2 (en) 2015-07-23 2024-02-28 Univ Hong Kong Chinese Analysis of the fragmentation pattern of cell-free DNA
WO2017020024A2 (en) * 2015-07-29 2017-02-02 Progenity, Inc. Systems and methods for genetic analysis
CN108350500A (en) 2015-07-29 2018-07-31 普罗格尼迪公司 Nucleic acid for detecting chromosome abnormality and method
EP3332037B1 (en) 2015-08-07 2021-02-24 University of Pittsburgh- Of the Commonwealth System of Higher Education Methods for predicting prostate cancer relapse
US11286531B2 (en) 2015-08-11 2022-03-29 The Johns Hopkins University Assaying ovarian cyst fluid
US11302416B2 (en) 2015-09-02 2022-04-12 Guardant Health Machine learning for somatic single nucleotide variant detection in cell-free tumor nucleic acid sequencing applications
EP3347466B9 (en) * 2015-09-08 2024-06-26 Cold Spring Harbor Laboratory Genetic copy number determination using high throughput multiplex sequencing of smashed nucleotides
EP3359694A4 (en) 2015-10-09 2019-07-17 Guardant Health, Inc. POPULATION-BASED TREATMENT RECOMMENDATION DEVICE USING DNA WITHOUT CELLS
KR101848438B1 (en) 2015-10-29 2018-04-13 바이오코아 주식회사 A method for prenatal diagnosis using digital PCR
CA3233310A1 (en) 2015-10-30 2017-05-04 Exact Sciences Development Company, Llc Multiplex amplification detection assay and isolation and detection of dna from plasma
DK3374525T3 (en) 2015-11-11 2021-04-06 Resolution Bioscience Inc HIGH-EFFICIENT CONSTRUCTION OF DNA LIBRARIES
WO2017087510A1 (en) * 2015-11-16 2017-05-26 Mayo Foundation For Medical Education And Research Detecting copy number variations
CA3006792A1 (en) 2015-12-08 2017-06-15 Twinstrand Biosciences, Inc. Improved adapters, methods, and compositions for duplex sequencing
SG11201805119QA (en) * 2015-12-17 2018-07-30 Guardant Health Inc Methods to determine tumor gene copy number by analysis of cell-free dna
WO2017127741A1 (en) * 2016-01-22 2017-07-27 Grail, Inc. Methods and systems for high fidelity sequencing
CN116640847A (en) 2016-02-02 2023-08-25 夸登特健康公司 Cancer evolution detection and diagnosis
US10095831B2 (en) 2016-02-03 2018-10-09 Verinata Health, Inc. Using cell-free DNA fragment size to determine copy number variations
US11479878B2 (en) 2016-03-16 2022-10-25 Dana-Farber Cancer Institute, Inc. Methods for genome characterization
BR112018069557A2 (en) 2016-03-25 2019-01-29 Karius Inc synthetic nucleic acid spike-ins
WO2017181146A1 (en) 2016-04-14 2017-10-19 Guardant Health, Inc. Methods for early detection of cancer
US11384382B2 (en) 2016-04-14 2022-07-12 Guardant Health, Inc. Methods of attaching adapters to sample nucleic acids
ITUA20162640A1 (en) * 2016-04-15 2017-10-15 Menarini Silicon Biosystems Spa METHOD AND KIT FOR THE GENERATION OF DNA LIBRARIES FOR PARALLEL MAXIMUM SEQUENCING
US12146195B2 (en) 2016-04-15 2024-11-19 Natera, Inc. Methods for lung cancer detection
US20170298422A1 (en) 2016-04-18 2017-10-19 The Board Of Trustees Of The Leland Stanford Junior University Simultaneous single-molecule epigenetic imaging of dna methylation and hydroxymethylation
CN109511265B (en) 2016-05-16 2023-07-14 安可济控股有限公司 A method for improving sequencing through strand identification
US10811539B2 (en) 2016-05-16 2020-10-20 Nanomedical Diagnostics, Inc. Graphene FET devices, systems, and methods of using the same for sequencing nucleic acids
US11499196B2 (en) 2016-06-07 2022-11-15 The Regents Of The University Of California Cell-free DNA methylation patterns for disease and condition analysis
CA3024984C (en) 2016-06-30 2021-12-07 Grail, Inc. Differential tagging of rna for preparation of a cell-free dna/rna sequencing library
CN107577917A (en) * 2016-07-05 2018-01-12 魏霖静 A kind of bioinformatics high performance information management system and data processing method
WO2018009723A1 (en) 2016-07-06 2018-01-11 Guardant Health, Inc. Methods for fragmentome profiling of cell-free nucleic acids
WO2018013837A1 (en) 2016-07-15 2018-01-18 The Regents Of The University Of California Methods of producing nucleic acid libraries
WO2018022890A1 (en) 2016-07-27 2018-02-01 Sequenom, Inc. Genetic copy number alteration classifications
CN117286217A (en) 2016-08-25 2023-12-26 分析生物科学有限公司 Method for detecting genomic copy changes in DNA samples
CN110024035B (en) * 2016-09-22 2023-11-14 Illumina公司 Somatic copy number change detection
US9850523B1 (en) 2016-09-30 2017-12-26 Guardant Health, Inc. Methods for multi-resolution analysis of cell-free nucleic acids
CN118460676A (en) 2016-09-30 2024-08-09 夸登特健康公司 Method for multi-resolution analysis of cell-free nucleic acids
US11485996B2 (en) 2016-10-04 2022-11-01 Natera, Inc. Methods for characterizing copy number variation using proximity-litigation sequencing
WO2018071595A1 (en) 2016-10-12 2018-04-19 Bellwether Bio, Inc. Determining cell type origin of circulating cell-free dna with molecular counting
MY195527A (en) 2016-10-24 2023-01-30 Grail Inc Methods And Systems For Tumor Detection
WO2018081465A1 (en) * 2016-10-26 2018-05-03 Pathway Genomics Corporation Systems and methods for characterizing nucleic acid in a biological sample
CN106566877A (en) * 2016-10-31 2017-04-19 天津诺禾致源生物信息科技有限公司 Gene mutation detection method and apparatus
JP2019534051A (en) 2016-11-15 2019-11-28 パーソナル ゲノム ダイアグノスティクス インコーポレイテッド Non-unique barcodes in genotyping assays
CA3039685A1 (en) 2016-11-30 2018-06-07 The Chinese University Of Hong Kong Analysis of cell-free dna in urine and other samples
US10011870B2 (en) 2016-12-07 2018-07-03 Natera, Inc. Compositions and methods for identifying nucleic acid molecules
US11101019B2 (en) * 2016-12-08 2021-08-24 Life Technologies Corporation Methods for detecting mutation load from a tumor sample
US20180166170A1 (en) * 2016-12-12 2018-06-14 Konstantinos Theofilatos Generalized computational framework and system for integrative prediction of biomarkers
IL302912A (en) 2016-12-22 2023-07-01 Guardant Health Inc Methods and systems for analyzing nucleic acid molecules
CN106701956A (en) * 2017-01-11 2017-05-24 上海思路迪生物医学科技有限公司 Technology for digitized deep sequencing of ctDNA
CA3049682C (en) 2017-01-20 2023-06-27 Sequenom, Inc. Methods for non-invasive assessment of genetic alterations
US11694768B2 (en) 2017-01-24 2023-07-04 Sequenom, Inc. Methods and processes for assessment of genetic variations
SG11201906397UA (en) * 2017-01-25 2019-08-27 Univ Hong Kong Chinese Diagnostic applications using nucleic acid fragments
JP7289264B2 (en) 2017-01-27 2023-06-09 エグザクト サイエンシーズ コーポレーション Detection of Colon Tumors by Analysis of Methylated DNA
US10894976B2 (en) 2017-02-21 2021-01-19 Natera, Inc. Compositions, methods, and kits for isolating nucleic acids
CN106755547A (en) * 2017-03-15 2017-05-31 上海亿康医学检验所有限公司 The Non-invasive detection and its recurrence monitoring method of a kind of carcinoma of urinary bladder
IL317916A (en) 2017-03-17 2025-02-01 Sequenom Inc Methods and processes for assessment of genetic mosaicism
WO2018183942A1 (en) 2017-03-31 2018-10-04 Grail, Inc. Improved library preparation and use thereof for sequencing-based error correction and/or variant identification
US10697008B2 (en) 2017-04-12 2020-06-30 Karius, Inc. Sample preparation methods, systems and compositions
US11342047B2 (en) 2017-04-21 2022-05-24 Illumina, Inc. Using cell-free DNA fragment size to detect tumor-associated variant
WO2018210877A1 (en) * 2017-05-15 2018-11-22 Katholieke Universiteit Leuven Method for analysing cell-free nucleic acids
ES2991960T3 (en) * 2017-05-16 2024-12-05 Guardant Health Inc Identification of the somatic or germinal origin of cell-free DNA
US10892037B2 (en) 2017-05-16 2021-01-12 Life Technologies Corporation Methods for compression of molecular tagged nucleic acid sequence data
KR102145417B1 (en) * 2017-05-24 2020-08-19 지니너스 주식회사 Method for generating distribution of background allele frequency for sequencing data obtained from cell-free nucleic acid and method for detecting mutation from cell-free nucleic acid using the same
EP3635133A4 (en) * 2017-06-09 2021-03-03 Bellwether Bio, Inc. Determination of cancer type in a subject by probabilistic modeling of circulating nucleic acid fragment endpoints
US20210151125A1 (en) * 2017-06-20 2021-05-20 Illumina, Inc. Methods and systems for decomposition and quantification of dna mixtures from multiple contributors of known or unknown genotypes
US20250006375A1 (en) * 2017-07-12 2025-01-02 University Health Network Cancer detection and classification using methylome analysis
US12054711B2 (en) 2017-07-14 2024-08-06 City Of Hope Meta-stable oligonucleotides junctions for delivery of therapeutics
EP3431611A1 (en) 2017-07-21 2019-01-23 Menarini Silicon Biosystems S.p.A. Improved method and kit for the generation of dna libraries for massively parallel sequencing
ES2959360T3 (en) * 2017-07-26 2024-02-23 Univ Hong Kong Chinese Improving cancer screening using acellular viral nucleic acids
JP6955732B2 (en) 2017-08-04 2021-10-27 ビリオントゥーワン, インコーポレイテッドBillionToOne, Inc. Sequencing output determination and analysis of target-related molecules in quantification of biological targets
WO2019028462A1 (en) 2017-08-04 2019-02-07 Billiontoone, Inc. Target-associated molecules for characterization associated with biological targets
US11519024B2 (en) 2017-08-04 2022-12-06 Billiontoone, Inc. Homologous genomic regions for characterization associated with biological targets
CA3072195A1 (en) 2017-08-07 2019-04-04 The Johns Hopkins University Methods and materials for assessing and treating cancer
US12385041B2 (en) 2017-08-10 2025-08-12 City Of Hope Conditional-siRNAS and uses thereof in treating cardiac hypertrophy
KR102722821B1 (en) 2017-09-20 2024-10-29 가던트 헬쓰, 인크. Methods and systems for distinguishing somatic and germline variants
CN107688726B (en) * 2017-09-21 2021-09-07 深圳市易基因科技有限公司 Method for judging single-gene-disease-related copy number deficiency based on liquid phase capture technology
US11099202B2 (en) 2017-10-20 2021-08-24 Tecan Genomics, Inc. Reagent delivery system
JP7304852B2 (en) 2017-11-03 2023-07-07 ガーダント ヘルス， インコーポレイテッド Correction of sequence errors induced by deamination
EP3704268B1 (en) 2017-11-03 2025-01-22 Guardant Health, Inc. Normalizing tumor mutation burden
EP3707273B1 (en) 2017-11-08 2024-04-10 Twinstrand Biosciences, Inc. Reagents and adapters for nucleic acid sequencing and methods for making such reagents and adapters
JP7054133B2 (en) * 2017-11-09 2022-04-13 国立研究開発法人国立がん研究センター Sequence analysis method, sequence analysis device, reference sequence generation method, reference sequence generator, program, and recording medium
NZ787685A (en) 2017-11-16 2024-11-29 Illumina Inc Systems and methods for determining microsatellite instability
EP3717662A1 (en) * 2017-11-28 2020-10-07 Grail, Inc. Models for targeted sequencing
CN110770838B (en) * 2017-12-01 2023-12-19 Illumina公司 Methods and systems for determining somatically mutated clonality
US10648025B2 (en) 2017-12-13 2020-05-12 Exact Sciences Development Company, Llc Multiplex amplification detection assay II
WO2019118926A1 (en) 2017-12-14 2019-06-20 Tai Diagnostics, Inc. Assessing graft suitability for transplantation
CN108197428B (en) * 2017-12-25 2020-06-19 西安交通大学 Copy number variation detection method for next generation sequencing technology based on parallel dynamic programming
CN112365927B (en) * 2017-12-28 2023-08-25 安诺优达基因科技(北京)有限公司 CNV detection device
EP3735470B1 (en) 2018-01-05 2023-11-22 BillionToOne, Inc. Quality control templates for ensuring validity of sequencing-based assays
AU2019207900B2 (en) 2018-01-12 2025-07-10 Claret Bioscience, Llc Methods and compositions for analyzing nucleic acid
CN110832510B (en) * 2018-01-15 2024-10-22 因美纳有限公司 Deep learning based variant classifier
CN108268752B (en) * 2018-01-18 2019-02-01 东莞博奥木华基因科技有限公司 A chromosomal abnormality detection device
KR102036609B1 (en) * 2018-02-12 2019-10-28 바이오코아 주식회사 A method for prenatal diagnosis using digital PCR
WO2019161244A1 (en) 2018-02-15 2019-08-22 Natera, Inc. Methods for isolating nucleic acids with size selection
GB201804642D0 (en) * 2018-03-22 2018-05-09 Inivata Ltd Methods of labelling nucleic acids
US11203782B2 (en) 2018-03-29 2021-12-21 Accuragen Holdings Limited Compositions and methods comprising asymmetric barcoding
DE202019005627U1 (en) 2018-04-02 2021-05-31 Grail, Inc. Methylation markers and targeted methylation probe panels
CN112334983A (en) 2018-04-13 2021-02-05 夸登特健康公司 Method for detecting and suppressing alignment errors caused by fusion events
JP7573443B2 (en) 2018-04-14 2024-10-25 ナテラ， インコーポレイテッド Methods for cancer detection and monitoring using personalized detection of circulating tumor dna - Patents.com
AU2019255613B2 (en) * 2018-04-16 2025-08-21 Memorial Sloan Kettering Cancer Center Systems and methods for detecting cancer via cfDNA screening
JP7590954B2 (en) * 2018-04-20 2024-11-27 バイオファイア・ダイアグノスティクス，リミテッド・ライアビリティ・カンパニー Methods for normalization and quantification of sequencing data
WO2019209954A1 (en) * 2018-04-24 2019-10-31 Grail, Inc. Systems and methods for using pathogen nucleic acid load to determine whether a subject has a cancer condition
EP3801623A4 (en) 2018-06-01 2022-03-23 Grail, LLC NEURAL CONVOLUTIONAL NETWORK SYSTEMS AND DATA CLASSIFICATION METHODS
US20190385700A1 (en) 2018-06-04 2019-12-19 Guardant Health, Inc. METHODS AND SYSTEMS FOR DETERMINING The CELLULAR ORIGIN OF CELL-FREE NUCLEIC ACIDS
JP7537748B2 (en) 2018-06-06 2024-08-21 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア Methods for generating nucleic acid libraries and compositions and kits for carrying out the same - Patents.com
CN112567081A (en) 2018-06-11 2021-03-26 基础医疗股份有限公司 Compositions and methods for assessing genomic alterations
CN109192246B (en) * 2018-06-22 2020-10-16 深圳市达仁基因科技有限公司 Method, apparatus and storage medium for detecting chromosomal copy number abnormalities
US12234509B2 (en) 2018-07-03 2025-02-25 Natera, Inc. Methods for detection of donor-derived cell-free DNA
CN118673964A (en) * 2018-07-11 2024-09-20 因美纳有限公司 Deep learning-based framework for identifying sequence patterns that cause sequence-specific errors (SSEs)
US12073922B2 (en) 2018-07-11 2024-08-27 Illumina, Inc. Deep learning-based framework for identifying sequence patterns that cause sequence-specific errors (SSEs)
SG11202100141SA (en) 2018-07-12 2021-02-25 Twinstrand Biosciences Inc Methods and reagents for characterizing genomic editing, clonal expansion, and associated applications
CN112752854B (en) 2018-07-23 2025-03-18 夸登特健康公司 Methods and systems for adjusting tumor mutation burden by tumor fraction and coverage
EP3830296A1 (en) * 2018-07-27 2021-06-09 F. Hoffmann-La Roche AG Method of monitoring effectiveness of immunotherapy of cancer patients
US12071651B2 (en) 2018-08-06 2024-08-27 Billiontoone, Inc. Dilution tagging for quantification of biological targets
WO2020033938A1 (en) 2018-08-10 2020-02-13 City Of Hope Programmable conditional sirnas and uses thereof
EP3841583A4 (en) * 2018-08-22 2022-05-18 The Regents of the University of California SENSITIVE DETECTION OF COPY NUMBER VARIATIONS (CNVS) FROM CIRCULATING ACELLULAR NUCLEIC ACID
SG11202101403YA (en) 2018-08-30 2021-03-30 Guardant Health Inc Methods and systems for detecting contamination between samples
EP3844760A1 (en) 2018-08-31 2021-07-07 Guardant Health, Inc. Genetic variant detection based on merged and unmerged reads
AU2019328344B2 (en) 2018-08-31 2025-06-12 Guardant Health, Inc. Microsatellite instability detection in cell-free DNA
EP3847276A2 (en) 2018-09-04 2021-07-14 Guardant Health, Inc. Methods and systems for detecting allelic imbalance in cell-free nucleic acid samples
WO2020056302A1 (en) * 2018-09-14 2020-03-19 The Jackson Laboratory Method and apparatus for detecting copy number variations in a genome
CN113286881A (en) 2018-09-27 2021-08-20 格里尔公司 Methylation signatures and target methylation probe plates
WO2020076772A1 (en) * 2018-10-08 2020-04-16 Freenome Holdings, Inc. Transcription factor profiling
CN109523520B (en) * 2018-10-25 2020-12-18 北京大学第三医院 An automatic counting method of chromosomes based on deep learning
CN113227393B (en) 2018-10-31 2025-02-11 夸登特健康公司 Methods, compositions and systems for calibrating epigenetic partitioning assays
EP4428234A3 (en) 2018-11-21 2024-09-25 Karius, Inc. Direct-to-library methods, systems, and compositions
CN109584961A (en) * 2018-12-03 2019-04-05 元码基因科技（北京）股份有限公司 Method based on two generation sequencing technologies detection blood microsatellite instability
US11581062B2 (en) 2018-12-10 2023-02-14 Grail, Llc Systems and methods for classifying patients with respect to multiple cancer classes
US20200202975A1 (en) * 2018-12-19 2020-06-25 AiOnco, Inc. Genetic information processing system with mutation analysis mechanism and method of operation thereof
CN109712671B (en) * 2018-12-20 2020-06-26 北京优迅医学检验实验室有限公司 Gene detection device based on ctDNA, storage medium and computer system
US20200232010A1 (en) 2018-12-20 2020-07-23 Guardant Health, Inc. Methods, compositions, and systems for improving recovery of nucleic acid molecules
CN111383714B (en) * 2018-12-29 2023-07-28 安诺优达基因科技(北京)有限公司 Method for simulating target disease simulation sequencing library and application thereof
JP7573536B2 (en) 2019-01-31 2024-10-25 ガーダント ヘルス， インコーポレイテッド Compositions and methods for isolating cell-free DNA
CN109841265B (en) * 2019-02-22 2021-09-21 清华大学 Method and system for determining tissue source of plasma free nucleic acid molecules by using fragmentation mode and application
WO2020176659A1 (en) 2019-02-27 2020-09-03 Guardant Health, Inc. Methods and systems for determining the cellular origin of cell-free dna
US20200273538A1 (en) 2019-02-27 2020-08-27 Guardant Health, Inc. Computational modeling of loss of function based on allelic frequency
CN111755075B (en) * 2019-03-28 2023-09-29 深圳华大生命科学研究院 Method for filtering sequence pollution among high-throughput sequencing samples of immune repertoire
WO2020206170A1 (en) 2019-04-02 2020-10-08 Progenity, Inc. Methods, systems, and compositions for counting nucleic acid molecules
EP3723096A1 (en) * 2019-04-12 2020-10-14 European Molecular Biology Laboratory Comprehensive detection of single cell genetic structural variations
CN110299185B (en) * 2019-05-08 2023-07-04 西安电子科技大学 A method and system for detecting insertional mutations based on next-generation sequencing data
WO2020243722A1 (en) * 2019-05-31 2020-12-03 Guardant Health, Inc. Methods and systems for improving patient monitoring after surgery
EP3980559A1 (en) 2019-06-06 2022-04-13 Natera, Inc. Methods for detecting immune cell dna and monitoring immune system
CN114585751A (en) * 2019-06-12 2022-06-03 阿尔缇玛基因组学公司 Method for accurate base determination using molecular barcodes
US12437840B2 (en) 2019-07-02 2025-10-07 International Business Machines Corporation Determining cell, tissue, or lesion representations in cell-free DNA
CN114616343A (en) 2019-09-30 2022-06-10 夸登特健康公司 Compositions and methods for analysis of cell-free DNA in methylation partition assays
CN110578002A (en) * 2019-10-10 2019-12-17 广州燃石医学检验所有限公司 Quality control product for detecting circulating tumor DNA mutation and preparation method thereof
MX2022004361A (en) * 2019-10-10 2022-05-03 Carlsberg As METHODS FOR PREPARING MUTANT PLANTS.
WO2021077411A1 (en) * 2019-10-25 2021-04-29 苏州宏元生物科技有限公司 Chromosome instability detection method, system and test kit
ES2971348T3 (en) 2019-10-25 2024-06-04 Guardant Health Inc 3' Overhang Repair Methods
CN114467144B (en) * 2019-10-25 2025-06-20 首尔大学校产学协力团 Somatic mutation detection device and method for reducing sequencing platform-specific errors
DE112020005433T5 (en) 2019-11-06 2022-10-06 The Board Of Trustees Of The Leland Stanford Junior University Methods and systems for analyzing nucleic acid molecules
CA3157560A1 (en) 2019-11-26 2021-06-03 Dustin Howard HITE Methods, compositions and systems for improving the binding of methylated polynucleotides
KR102184277B1 (en) * 2020-01-16 2020-11-30 성균관대학교산학협력단 All-in-one ai self health care apparatus for ultrasound diagnosis and dna check-up, and remote medical-diagnosis method using the same
US20210398610A1 (en) 2020-01-31 2021-12-23 Guardant Health, Inc. Significance modeling of clonal-level absence of target variants
US12059674B2 (en) 2020-02-03 2024-08-13 Tecan Genomics, Inc. Reagent storage system
US11475981B2 (en) 2020-02-18 2022-10-18 Tempus Labs, Inc. Methods and systems for dynamic variant thresholding in a liquid biopsy assay
US11211147B2 (en) 2020-02-18 2021-12-28 Tempus Labs, Inc. Estimation of circulating tumor fraction using off-target reads of targeted-panel sequencing
US11211144B2 (en) 2020-02-18 2021-12-28 Tempus Labs, Inc. Methods and systems for refining copy number variation in a liquid biopsy assay
JP2023517029A (en) 2020-03-11 2023-04-21 ガーダント ヘルス， インコーポレイテッド Methods for Classifying Genetic Mutations Detected in Cell-Free Nucleic Acids as Tumor or Non-Tumor Origin
CN111445950B (en) * 2020-03-19 2022-10-25 西安交通大学 High-fault-tolerance genome complex structure variation detection method based on filtering strategy
CN113436679B (en) * 2020-03-23 2024-05-10 北京合生基因科技有限公司 Method and system for determining mutation rate of nucleic acid sample to be tested
EP4143338A1 (en) 2020-04-30 2023-03-08 Guardant Health, Inc. Methods for sequence determination using partitioned nucleic acids
US20230183811A1 (en) * 2020-05-14 2023-06-15 Georgia Tech Research Corporation Methods of detecting the efficacy of anticancer agents
US12241126B2 (en) 2020-05-14 2025-03-04 Guardant Health, Inc. Homologous recombination repair deficiency detection
WO2023282916A1 (en) 2021-07-09 2023-01-12 Guardant Health, Inc. Methods of detecting genomic rearrangements using cell free nucleic acids
EP4179111B1 (en) 2020-07-10 2024-04-03 Guardant Health, Inc. Methods of detecting genomic rearrangements using cell free nucleic acids
EP4585697A3 (en) 2020-07-30 2025-08-06 Guardant Health, Inc. Methods for isolating cell-free dna
EP4205126A1 (en) 2020-08-25 2023-07-05 Guardant Health, Inc. Methods and systems for predicting an origin of a variant
WO2022046804A2 (en) 2020-08-25 2022-03-03 Seer, Inc. Compositions and methods for assaying proteins and nucleic acids
US20220068433A1 (en) 2020-08-27 2022-03-03 Guardant Health, Inc. Computational detection of copy number variation at a locus in the absence of direct measurement of the locus
CA3193090A1 (en) 2020-09-30 2022-04-07 Guardant Health, Inc. Methods and systems to improve the signal to noise ratio of dna methylation partitioning assays
CA3195797A1 (en) 2020-10-23 2022-04-28 Andrew Kennedy Compositions and methods for analyzing dna using partitioning and base conversion
CA3199829A1 (en) 2020-11-30 2022-06-02 Guardant Health, Inc. Compositions and methods for enriching methylated polynucleotides
WO2022140629A1 (en) 2020-12-23 2022-06-30 Guardant Health, Inc. Methods and systems for analyzing methylated polynucleotides
CN112735516A (en) * 2020-12-29 2021-04-30 上海派森诺生物科技股份有限公司 Group variation detection analysis method without reference genome
CN112908411B (en) * 2021-01-12 2024-05-14 广州市金域转化医学研究院有限公司 Mitochondrial variation site database and establishment method and application thereof
WO2022174109A1 (en) 2021-02-12 2022-08-18 Guardant Health, Inc. Methods and compositions for detecting nucleic acid variants
JP2024513668A (en) 2021-03-05 2024-03-27 ガーダント ヘルス， インコーポレイテッド Methods and related aspects for analyzing molecular responses
WO2022192889A1 (en) 2021-03-09 2022-09-15 Guardant Health, Inc. Detecting the presence of a tumor based on off-target polynucleotide sequencing data
EP4314329A1 (en) 2021-03-25 2024-02-07 Guardant Health, Inc. Methods and compositions for quantifying immune cell dna
CN113130005B (en) * 2021-04-12 2022-11-22 中国科学院东北地理与农业生态研究所 M2 group-based candidate causal mutation site gene positioning method
US11783912B2 (en) 2021-05-05 2023-10-10 The Board Of Trustees Of The Leland Stanford Junior University Methods and systems for analyzing nucleic acid molecules
JP2024520422A (en) 2021-05-28 2024-05-24 ガーダント ヘルス， インコーポレイテッド Compositions and methods for assaying circulating molecules
CN113284555B (en) * 2021-06-11 2023-08-22 中山大学 Construction method, device, equipment and storage medium of gene mutation network
WO2022271730A1 (en) 2021-06-21 2022-12-29 Guardant Health, Inc. Methods and compositions for copy-number informed tissue-of-origin analysis
CN118202417A (en) * 2021-07-06 2024-06-14 斯威齐治疗公司 Method for activating small interference RNA sensor by design condition
US20250250636A1 (en) * 2021-08-10 2025-08-07 Cornell University Ultra-sensitive liquid biopsy through deep learning empowered whole genome sequencing of plasma
WO2023056065A1 (en) 2021-09-30 2023-04-06 Guardant Health, Inc. Compositions and methods for synthesis and use of probes targeting nucleic acid rearrangements
CN118355131A (en) * 2021-10-04 2024-07-16 香港中文大学 Viral DNA sequencing for predicting disease recurrence
JP2024540168A (en) 2021-11-02 2024-10-31 ガーダント ヘルス， インコーポレイテッド Quality Control Methods
WO2023097325A2 (en) * 2021-11-29 2023-06-01 Mammoth Biosciences, Inc. Systems and methods for identifying genetic phenotypes using programmable nucleases
CN114703263B (en) * 2021-12-20 2023-09-22 北京科迅生物技术有限公司 Group chromosome copy number variation detection method and device
EP4453241A1 (en) 2021-12-21 2024-10-30 Guardant Health, Inc. Methods and systems for combinatorial chromatin-ip sequencing
EP4453240A1 (en) 2021-12-23 2024-10-30 Guardant Health, Inc. Compositions and methods for detection of metastasis
EP4496900A2 (en) 2022-03-21 2025-01-29 BILLION ToONE, INC. Molecule counting of methylated cell-free dna for treatment monitoring
JP2025513786A (en) 2022-04-07 2025-04-30 ガーダント ヘルス， インコーポレイテッド DETECTING THE PRESENCE OF TUMOR BASED ON THE METHYLATION STATUS OF CELL-FREE NUCLEIC ACID MOLECULES - Patent application
CN114724628B (en) * 2022-04-24 2022-11-08 华中农业大学 Method for identifying and annotating polynucleotide variation of multiple species
US20230360725A1 (en) 2022-05-09 2023-11-09 Guardant Health, Inc. Detecting degradation based on strand bias
WO2024006908A1 (en) 2022-06-30 2024-01-04 Guardant Health, Inc. Enrichment of aberrantly methylated dna
US20240191290A1 (en) 2022-07-21 2024-06-13 Guardant Health, Inc. Methods for detection and reduction of sample preparation-induced methylation artifacts
WO2024059840A1 (en) 2022-09-16 2024-03-21 Guardant Health, Inc. Compositions and methods for analyzing soluble proteins
EP4594522A2 (en) 2022-09-27 2025-08-06 Guardant Health, Inc. Methods for quantifying immune cell dna
AU2023381788A1 (en) 2022-11-15 2025-05-15 Guardant Health, Inc. Method of predicting non-small cell lung cancer (nsclc) patient drug response or time until death or cancer progression from circulating tumor dna (ctdna) utilizing signals from both baseline ctdna level and longitudinal change of ctdna level over time
CN120226085A (en) 2022-11-17 2025-06-27 夸登特健康公司 Verification of bioinformatics model for classifying non-tumor variations in cell-free DNA liquid biopsy assays
US20240412815A1 (en) 2022-12-21 2024-12-12 Guardant Health, Inc. Detecting homologous recombination deficiences based on methylation status of cell-free nucleic acid molecules
WO2024137880A2 (en) 2022-12-22 2024-06-27 Guardant Health, Inc. Methods involving methylation preserving amplification with error correction
WO2024138180A2 (en) 2022-12-22 2024-06-27 Guardant Health, Inc. Integrated targeted and whole genome somatic and dna methylation sequencing workflows
CN120604294A (en) 2023-01-11 2025-09-05 夸登特健康公司 Joint modeling of longitudinal data and time-to-event data to predict patient survival
WO2024159053A1 (en) 2023-01-25 2024-08-02 Guardant Health, Inc. Nucleic acid methylation profiling method
CN115798580B (en) * 2023-02-10 2023-11-07 北京中仪康卫医疗器械有限公司 Genotype filling and low-depth sequencing-based integrated genome analysis method
WO2024211717A1 (en) 2023-04-07 2024-10-10 Guardant Health, Inc. Detecting the presence of a tumor based on methylation status of cell-free nucleic acid molecules
US20250101522A1 (en) 2023-04-12 2025-03-27 Guardant Health, Inc. Brca1 promoter methylation in sporadic breast cancer patients detected by liquid biopsy
WO2024229143A1 (en) 2023-05-01 2024-11-07 Guardant Health, Inc. Quality control method for enzymatic conversion procedures
WO2024229433A1 (en) 2023-05-03 2024-11-07 Guardant Health, Inc. Methods for analysis of dna methylation
WO2024233502A1 (en) 2023-05-05 2024-11-14 Guardant Health, Inc. Cell-free dna blood-based test for cancer screening
WO2024259251A1 (en) 2023-06-15 2024-12-19 Guardant Health, Inc. Method for hrd detection in targeted cfdna samples using de novo mutational signatures
WO2024264065A1 (en) 2023-06-23 2024-12-26 Guardant Health, Inc. Methods and compositions for quantifying immune cell nucleic acids
WO2025007034A1 (en) 2023-06-29 2025-01-02 Guardant Health, Inc. Methods for determining surveillance and therapy for diseases
WO2025029475A1 (en) 2023-07-28 2025-02-06 Guardant Health, Inc. Methods to enrich nucleotide variants by negative selection
WO2025038399A1 (en) 2023-08-11 2025-02-20 Guardant Health, Inc. Methylated enrichment methods for single-molecule genetic and epigenetic sequencing
WO2025059338A1 (en) 2023-09-12 2025-03-20 Guardant Health, Inc. Methods for analyzing nucleic acids using sequence read family size distribution
WO2025064706A1 (en) 2023-09-19 2025-03-27 Guardant Health, Inc. Detecting the presence of a tumor based on methylation status of cell-free nucleic acid molecules
US20250246266A1 (en) 2023-09-29 2025-07-31 Guardant Health, Inc. Genotyping cyp2d6
WO2025076452A1 (en) 2023-10-06 2025-04-10 Guardant Health, Inc. Detecting tumor-related information based on methylation status of cell-free nucleic acid molecules
US20250250638A1 (en) 2023-10-06 2025-08-07 Guardant Health, Inc. Genomic and methylation biomarkers for prediction of copy number loss / gene deletion
WO2025079958A1 (en) * 2023-10-11 2025-04-17 고려대학교 산학협력단 High-throughput mutant-specific adapter ligation method
WO2025085784A1 (en) 2023-10-18 2025-04-24 Guardant Health, Inc. Genomic and methylation biomarkers for determining patient risk of heart disease and novel genomic and epigenomic drug targets to decrease risk of heart disease and/or improve patient outcome after myocardial infarction or cardiac injury
WO2025090954A1 (en) 2023-10-26 2025-05-01 Guardant Health, Inc. Methods for detecting nucleic acid variants
WO2025090956A1 (en) 2023-10-26 2025-05-01 Guardant Health, Inc. Methods for detecting nucleic acid variants using capture probes
WO2025090646A1 (en) 2023-10-27 2025-05-01 Guardant Health, Inc. Monitoring molecular response by allelic imbalance
WO2025106263A1 (en) 2023-11-15 2025-05-22 Guardant Health, Inc. Joint modeling of longitudinal and time-to-event data to predict patient survival
US20250243550A1 (en) 2023-11-15 2025-07-31 Guardant Health, Inc. Minimum residual disease (mrd) detection in early stage cancer using urine
WO2025137620A1 (en) 2023-12-21 2025-06-26 Guardant Health, Inc. Methods for high quality and high accuracy methylation sequencing
WO2025137389A2 (en) 2023-12-22 2025-06-26 Guardant Health, Inc. Methods for targeted single-molecule genetic and epigenetic sequencing
WO2025160433A1 (en) * 2024-01-24 2025-07-31 Guardant Health, Inc. Methods for analyzing sequencing reads
WO2025207817A1 (en) 2024-03-26 2025-10-02 Guardant Health, Inc. Method of determining the likelihood of a disease by combining biomarkers and imaging
US20250308636A1 (en) 2024-03-27 2025-10-02 Guardant Health, Inc. Inferring cnvs from the distribution of molecules in hyper partition
WO2025208044A1 (en) 2024-03-28 2025-10-02 Guardant Health, Inc. Methods for cancer detection using molecular patterns
WO2025207926A1 (en) 2024-03-28 2025-10-02 Guardant Health, Inc. Methods for selective deamination using methyl-sensitive deaminases

Family Cites Families (279)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US604804A (en) * 1898-05-31 Shuttle for looms
US4725536A (en) 1985-09-19 1988-02-16 Genetics Institute, Inc. Reagent polynucleotide complex with multiple target binding regions, and kit and methods
US6150517A (en) 1986-11-24 2000-11-21 Gen-Probe Methods for making oligonucleotide probes for the detection and/or quantitation of non-viral organisms
US5149625A (en) 1987-08-11 1992-09-22 President And Fellows Of Harvard College Multiplex analysis of DNA
US4942124A (en) 1987-08-11 1990-07-17 President And Fellows Of Harvard College Multiplex sequencing
US5656731A (en) 1987-10-15 1997-08-12 Chiron Corporation Nucleic acid-amplified immunoassay probes
US5124246A (en) 1987-10-15 1992-06-23 Chiron Corporation Nucleic acid multimers and amplified nucleic acid hybridization assays using same
US5744101A (en) 1989-06-07 1998-04-28 Affymax Technologies N.V. Photolabile nucleoside protecting groups
US6309822B1 (en) 1989-06-07 2001-10-30 Affymetrix, Inc. Method for comparing copy number of nucleic acid sequences
US5143854A (en) 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
US5871928A (en) 1989-06-07 1999-02-16 Fodor; Stephen P. A. Methods for nucleic acid analysis
US6551784B2 (en) 1989-06-07 2003-04-22 Affymetrix Inc Method of comparing nucleic acid sequences
US5424186A (en) 1989-06-07 1995-06-13 Affymax Technologies N.V. Very large scale immobilized polymer synthesis
US5925525A (en) 1989-06-07 1999-07-20 Affymetrix, Inc. Method of identifying nucleotide differences
US5800992A (en) 1989-06-07 1998-09-01 Fodor; Stephen P.A. Method of detecting nucleic acids
US6040138A (en) 1995-09-15 2000-03-21 Affymetrix, Inc. Expression monitoring by hybridization to high density oligonucleotide arrays
US5200314A (en) 1990-03-23 1993-04-06 Chiron Corporation Polynucleotide capture assay employing in vitro amplification
EP0834576B1 (en) 1990-12-06 2002-01-16 Affymetrix, Inc. (a Delaware Corporation) Detection of nucleic acid sequences
US6582908B2 (en) 1990-12-06 2003-06-24 Affymetrix, Inc. Oligonucleotides
US5981179A (en) 1991-11-14 1999-11-09 Digene Diagnostics, Inc. Continuous amplification reaction
US5424413A (en) 1992-01-22 1995-06-13 Gen-Probe Incorporated Branched nucleic acid probes
US5573905A (en) 1992-03-30 1996-11-12 The Scripps Research Institute Encoded combinatorial chemical libraries
US6020124A (en) 1992-04-27 2000-02-01 Trustees Of Dartmouth College Detection of soluble gene sequences in biological fluids
US5981176A (en) 1992-06-17 1999-11-09 City Of Hope Method of detecting and discriminating between nucleic acid sequences
JP3954092B2 (en) 1993-06-25 2007-08-08 アフィメトリックス インコーポレイテッド Nucleic acid sequence hybridization and sequencing
US5500356A (en) 1993-08-10 1996-03-19 Life Technologies, Inc. Method of nucleic acid sequence selection
US6309823B1 (en) 1993-10-26 2001-10-30 Affymetrix, Inc. Arrays of nucleic acid probes for analyzing biotransformation genes and methods of using the same
US5681697A (en) 1993-12-08 1997-10-28 Chiron Corporation Solution phase nucleic acid sandwich assays having reduced background noise and kits therefor
CH686982A5 (en) 1993-12-16 1996-08-15 Maurice Stroun Method for diagnosis of cancers.
US20030017081A1 (en) 1994-02-10 2003-01-23 Affymetrix, Inc. Method and apparatus for imaging a sample on a device
US5714330A (en) 1994-04-04 1998-02-03 Lynx Therapeutics, Inc. DNA sequencing by stepwise ligation and cleavage
US6013445A (en) 1996-06-06 2000-01-11 Lynx Therapeutics, Inc. Massively parallel signature sequencing by ligation of encoded adaptors
US5604097A (en) 1994-10-13 1997-02-18 Spectragen, Inc. Methods for sorting polynucleotides using oligonucleotide tags
US5695934A (en) 1994-10-13 1997-12-09 Lynx Therapeutics, Inc. Massively parallel sequencing of sorted polynucleotides
US5846719A (en) 1994-10-13 1998-12-08 Lynx Therapeutics, Inc. Oligonucleotide tags for sorting and identification
WO1998053300A2 (en) 1997-05-23 1998-11-26 Lynx Therapeutics, Inc. System and apparaus for sequential processing of analytes
US6600996B2 (en) 1994-10-21 2003-07-29 Affymetrix, Inc. Computer-aided techniques for analyzing biological sequences
ES2271944T3 (en) 1994-10-28 2007-04-16 Gen-Probe Incorporated COMPOSITIONS AND METHODS FOR SIMULTANEOUS DETECTION AND QUANTIFICATION OF MULTIPLE SPECIFIC SEQUENCES OF NUCLEIC ACIDS.
US5648245A (en) 1995-05-09 1997-07-15 Carnegie Institution Of Washington Method for constructing an oligonucleotide concatamer library by rolling circle replication
US5968740A (en) 1995-07-24 1999-10-19 Affymetrix, Inc. Method of Identifying a Base in a Nucleic Acid
GB9516636D0 (en) 1995-08-14 1995-10-18 Univ London In-situ nucleic acid amplification and detection
US5763175A (en) 1995-11-17 1998-06-09 Lynx Therapeutics, Inc. Simultaneous sequencing of tagged polynucleotides
US5854033A (en) 1995-11-21 1998-12-29 Yale University Rolling circle replication reporter systems
CA2248981C (en) 1996-03-15 2009-11-24 The Penn State Research Foundation Detection of extracellular tumor-associated nucleic acid in blood plasma or serum using nucleic acid amplification assays
US6329179B1 (en) 1996-03-26 2001-12-11 Oncomedx, Inc. Method enabling use of extracellular RNA extracted from plasma or serum to detect, monitor or evaluate cancer
US6458530B1 (en) 1996-04-04 2002-10-01 Affymetrix Inc. Selecting tag nucleic acids
US6300077B1 (en) 1996-08-14 2001-10-09 Exact Sciences Corporation Methods for the detection of nucleic acids
US5935793A (en) 1996-09-27 1999-08-10 The Chinese University Of Hong Kong Parallel polynucleotide sequencing method using tagged primers
US6124092A (en) 1996-10-04 2000-09-26 The Perkin-Elmer Corporation Multiplex polynucleotide capture methods and compositions
US6117631A (en) 1996-10-29 2000-09-12 Polyprobe, Inc. Detection of antigens via oligonucleotide antibody conjugates
US6046005A (en) 1997-01-15 2000-04-04 Incyte Pharmaceuticals, Inc. Nucleic acid sequencing with solid phase capturable terminators comprising a cleavable linking group
AU1603199A (en) 1997-12-03 1999-06-16 Curagen Corporation Methods and devices for measuring differential gene expression
WO2000012687A1 (en) 1998-08-28 2000-03-09 Invitrogen Corporation System for the rapid manipulation of nucleic acid sequences
WO2000014282A1 (en) 1998-09-04 2000-03-16 Lynx Therapeutics, Inc. Method of screening for genetic polymorphism
US6503718B2 (en) 1999-01-10 2003-01-07 Exact Sciences Corporation Methods for detecting mutations using primer extension for detecting disease
JP2002535999A (en) 1999-02-05 2002-10-29 アマシャム バイオサイエンス ユーケイ リミテッド Genome analysis method
US6629040B1 (en) 1999-03-19 2003-09-30 University Of Washington Isotope distribution encoded tags for protein identification
JP2002539849A (en) 1999-03-26 2002-11-26 ホワイトヘッド インスチチュート フォアー バイオメディカル リサーチ Universal array
DE60029092T2 (en) 1999-04-09 2007-02-01 Exact Sciences Corp., Marlborough METHOD FOR DETECTING NUCLEIC ACIDS REFERRING TO CANCER INSTRUCTIONS
US6355431B1 (en) 1999-04-20 2002-03-12 Illumina, Inc. Detection of nucleic acid amplification reactions using bead arrays
CA2304260C (en) 1999-04-20 2009-03-24 Japan Bioindustry Association Method for determining a concentration of target nucleic acid molecules, nucleic acid probes for the method and method for analyzing data obtained by the method
US6242186B1 (en) 1999-06-01 2001-06-05 Oy Jurilab Ltd. Method for detecting a risk of cancer and coronary heart disease and kit therefor
US6326148B1 (en) 1999-07-12 2001-12-04 The Regents Of The University Of California Detection of copy number changes in colon cancer
US6440706B1 (en) 1999-08-02 2002-08-27 Johns Hopkins University Digital amplification
US6849403B1 (en) 1999-09-08 2005-02-01 Exact Sciences Corporation Apparatus and method for drug screening
US6586177B1 (en) 1999-09-08 2003-07-01 Exact Sciences Corporation Methods for disease detection
AU4714201A (en) 1999-12-07 2001-06-18 Exact Sciences Corporation Supracolonic aerodigestive neoplasm detection
US6489114B2 (en) 1999-12-17 2002-12-03 Bio Merieux Process for labeling a ribonucleic acid, and labeled RNA fragments which are obtained thereby
ATE411397T1 (en) 2000-02-07 2008-10-15 Illumina Inc NUCLEIC ACID DETECTION METHOD WITH UNIVERSAL PRIMING
US20020072058A1 (en) 2000-03-24 2002-06-13 Voelker Leroy L. Method for amplifying quinolone-resistance-determining-regions and identifying polymorphic variants thereof
US20030207300A1 (en) 2000-04-28 2003-11-06 Matray Tracy J. Multiplex analytical platform using molecular tags
EP1158055A1 (en) 2000-05-26 2001-11-28 Xu Qi University of Teaxs Laboratoire de Leucémie Chen Method for diagnosing cancers
EP1366192B8 (en) 2000-10-24 2008-10-29 The Board of Trustees of the Leland Stanford Junior University Direct multiplex characterization of genomic dna
US20020142345A1 (en) 2000-12-22 2002-10-03 Nelsen Anita J. Methods for encoding and decoding complex mixtures in arrayed assays
US20030049616A1 (en) 2001-01-08 2003-03-13 Sydney Brenner Enzymatic synthesis of oligonucleotide tags
US6428964B1 (en) 2001-03-15 2002-08-06 Exact Sciences Corporation Method for alteration detection
CA2344599C (en) 2001-05-07 2011-07-12 Bioneer Corporation Selective polymerase chain reaction of dna of which base sequence is completely unknown
US7406385B2 (en) 2001-10-25 2008-07-29 Applera Corporation System and method for consensus-calling with per-base quality values for sample assemblies
DK1342794T3 (en) 2002-03-05 2006-04-24 Epigenomics Ag Method and apparatus for determining tissue specificity of free-flowing DNA in body fluids
US20030186251A1 (en) 2002-04-01 2003-10-02 Brookhaven Science Associates, Llc Genome sequence tags
US7727720B2 (en) 2002-05-08 2010-06-01 Ravgen, Inc. Methods for detection of genetic disorders
AU2003291481A1 (en) 2002-11-11 2004-06-03 Affymetrix, Inc. Methods for identifying dna copy number changes
US7822555B2 (en) 2002-11-11 2010-10-26 Affymetrix, Inc. Methods for identifying DNA copy number changes
US10229244B2 (en) 2002-11-11 2019-03-12 Affymetrix, Inc. Methods for identifying DNA copy number changes using hidden markov model based estimations
US7704687B2 (en) 2002-11-15 2010-04-27 The Johns Hopkins University Digital karyotyping
WO2004081183A2 (en) 2003-03-07 2004-09-23 Rubicon Genomics, Inc. In vitro dna immortalization and whole genome amplification using libraries generated from randomly fragmented dna
WO2006102264A1 (en) 2005-03-18 2006-09-28 Fluidigm Corporation Thermal reaction device and method for using the same
US20040259118A1 (en) 2003-06-23 2004-12-23 Macevicz Stephen C. Methods and compositions for nucleic acid sequence analysis
CA2531105C (en) 2003-07-05 2015-03-17 The Johns Hopkins University Method and compositions for detection and enumeration of genetic variations
EP1524321B2 (en) 2003-10-16 2014-07-23 Sequenom, Inc. Non-invasive detection of fetal genetic traits
DE10348407A1 (en) 2003-10-17 2005-05-19 Widschwendter, Martin, Prof. Prognostic and diagnostic markers for cell proliferative disorders of breast tissues
US20070111233A1 (en) 2003-10-30 2007-05-17 Bianchi Diana W Prenatal diagnosis using cell-free fetal DNA in amniotic fluid
CA2552858A1 (en) 2004-01-23 2005-08-04 Lingvitae As Improving polynucleotide ligation reactions
DE602005018166D1 (en) 2004-02-12 2010-01-21 Population Genetics Technologi GENETIC ANALYSIS BY SEQUENCE-SPECIFIC SORTING
US20100216153A1 (en) 2004-02-27 2010-08-26 Helicos Biosciences Corporation Methods for detecting fetal nucleic acids and diagnosing fetal abnormalities
US20060046258A1 (en) 2004-02-27 2006-03-02 Lapidus Stanley N Applications of single molecule sequencing
US20050250147A1 (en) 2004-05-10 2005-11-10 Macevicz Stephen C Digital profiling of polynucleotide populations
US7276720B2 (en) 2004-07-19 2007-10-02 Helicos Biosciences Corporation Apparatus and methods for analyzing samples
US20060035258A1 (en) 2004-08-06 2006-02-16 Affymetrix, Inc. Methods for identifying DNA copy number changes
US7937225B2 (en) 2004-09-03 2011-05-03 New York University Systems, methods and software arrangements for detection of genome copy number variation
EP1647600A3 (en) 2004-09-17 2006-06-28 Affymetrix, Inc. (A US Entity) Methods for identifying biological samples by addition of nucleic acid bar-code tags
US9109256B2 (en) 2004-10-27 2015-08-18 Esoterix Genetic Laboratories, Llc Method for monitoring disease progression or recurrence
US7424371B2 (en) 2004-12-21 2008-09-09 Helicos Biosciences Corporation Nucleic acid analysis
US7393665B2 (en) 2005-02-10 2008-07-01 Population Genetics Technologies Ltd Methods and compositions for tagging and identifying polynucleotides
ITRM20050068A1 (en) 2005-02-17 2006-08-18 Istituto Naz Per Le Malattie I METHOD FOR THE DETECTION OF NUCLEIC ACIDS OF BACTERIAL OR PATENT PATOGEN AGENTS IN URINE.
WO2006099604A2 (en) 2005-03-16 2006-09-21 Compass Genetics, Llc Methods and compositions for assay readouts on multiple analytical platforms
DE602005009324D1 (en) 2005-04-06 2008-10-09 Maurice Stroun Method for cancer diagnosis by detection of DNA and RNA in the circulation
US20070020640A1 (en) 2005-07-21 2007-01-25 Mccloskey Megan L Molecular encoding of nucleic acid templates for PCR and other forms of sequence analysis
US7666593B2 (en) 2005-08-26 2010-02-23 Helicos Biosciences Corporation Single molecule sequencing of captured nucleic acids
DK1929039T4 (en) 2005-09-29 2014-02-17 Keygene Nv High throughput-screening af mutageniserede populationer
WO2007087312A2 (en) 2006-01-23 2007-08-02 Population Genetics Technologies Ltd. Molecular counting
US20070172839A1 (en) 2006-01-24 2007-07-26 Smith Douglas R Asymmetrical adapters and methods of use thereof
US8383338B2 (en) 2006-04-24 2013-02-26 Roche Nimblegen, Inc. Methods and systems for uniform enrichment of genomic regions
US7702468B2 (en) 2006-05-03 2010-04-20 Population Diagnostics, Inc. Evaluating genetic disorders
WO2007137187A2 (en) 2006-05-18 2007-11-29 Molecular Profiling Institute, Inc. System and method for determining individualized medical intervention for a disease state
WO2008111990A1 (en) 2006-06-14 2008-09-18 Cellpoint Diagnostics, Inc. Rare cell analysis using sample splitting and dna tags
FR2904833A1 (en) 2006-08-11 2008-02-15 Bioquanta Sarl Determining the quantity of nucleic acid, particularly DNA or RNA in a sample comprises adding a fluorophore to the sample, measuring fluorescence intensities in response to luminous stimulations and removing the nucleic acids
WO2008061193A2 (en) 2006-11-15 2008-05-22 Biospherex Llc Multitag sequencing and ecogenomics analysis
WO2008070144A2 (en) 2006-12-06 2008-06-12 Duke University Imprinted genes and disease
CN104043123B (en) 2007-01-25 2019-08-13 达娜-法勃肿瘤研究所公司 Purposes of the anti-egfr antibodies in the mutant mediated disease for the treatment of EGFR
EP2121989B2 (en) 2007-03-13 2022-03-09 Amgen Inc. K-ras mutations and anti-egfr antibody therapy
WO2008148072A2 (en) 2007-05-24 2008-12-04 The Brigham And Women's Hospital, Inc. Disease-associated genetic variations and methods for obtaining and using same
EP2164985A4 (en) 2007-06-01 2014-05-14 454 Life Sciences Corp SYSTEM AND METHOD FOR IDENTIFYING INDIVIDUAL SAMPLES FROM A MULTIPLEX MIXTURE
CA2689626C (en) * 2007-06-06 2016-10-25 Pacific Biosciences Of California, Inc. Methods and processes for calling bases in sequence by incorporation methods
US12180549B2 (en) 2007-07-23 2024-12-31 The Chinese University Of Hong Kong Diagnosing fetal chromosomal aneuploidy using genomic sequencing
CA3127930A1 (en) 2007-07-23 2009-01-29 The Chinese Unversity Of Hongkong Diagnosing fetal chromosomal aneuploidy using genomic sequencing
US20090053719A1 (en) 2007-08-03 2009-02-26 The Chinese University Of Hong Kong Analysis of nucleic acids by digital pcr
EA018555B1 (en) 2007-09-07 2013-08-30 Флуидигм Корпорейшн Copy number variation determination, methods and systems
US20100173294A1 (en) 2007-09-11 2010-07-08 Roche Molecular Systems, Inc. Diagnostic test for susceptibility to b-raf kinase inhibitors
DK3144672T3 (en) 2007-11-21 2018-12-03 Cosmosid Inc GENOME IDENTIFICATION SYSTEM
BRPI0908128A2 (en) 2008-02-12 2015-08-04 Novartis Ag Method for Isolation of Cell Free Apoptotic or Fetal Nucleic Acids
US20110003701A1 (en) 2008-02-27 2011-01-06 454 Life Sciences Corporation System and method for improved processing of nucleic acids for production of sequencable libraries
US8216789B2 (en) 2008-02-27 2012-07-10 University Of Washington Diagnostic panel of cancer antibodies and methods for use
CA2718137A1 (en) 2008-03-26 2009-10-01 Sequenom, Inc. Restriction endonuclease enhanced polymorphic sequence detection
JP2011515102A (en) 2008-03-28 2011-05-19 パシフィック バイオサイエンシーズ オブ カリフォルニア， インコーポレイテッド Compositions and methods for nucleic acid sequencing
WO2009143379A2 (en) 2008-05-21 2009-11-26 Fred Hutchinson Cancer Research Center Use of extracellular rna to measure disease
US20090298709A1 (en) 2008-05-28 2009-12-03 Affymetrix, Inc. Assays for determining telomere length and repeated sequence copy number
DE102008025656B4 (en) 2008-05-28 2016-07-28 Genxpro Gmbh Method for the quantitative analysis of nucleic acids, markers therefor and their use
CN102165073A (en) 2008-07-10 2011-08-24 骆树恩 Method for mapping nucleic acids and identifying fine structural changes in nucleic acids
US20100041048A1 (en) 2008-07-31 2010-02-18 The Johns Hopkins University Circulating Mutant DNA to Assess Tumor Dynamics
US20100062494A1 (en) 2008-08-08 2010-03-11 President And Fellows Of Harvard College Enzymatic oligonucleotide pre-adenylation
WO2010021936A1 (en) 2008-08-16 2010-02-25 The Board Of Trustees Of The Leland Stanford Junior University Digital pcr calibration for high throughput sequencing
GB2467691A (en) 2008-09-05 2010-08-11 Aueon Inc Methods for stratifying and annotating cancer drug treatment options
US8383345B2 (en) 2008-09-12 2013-02-26 University Of Washington Sequence tag directed subassembly of short sequencing reads into long sequencing reads
EP2562268B1 (en) 2008-09-20 2016-12-21 The Board of Trustees of The Leland Stanford Junior University Noninvasive diagnosis of fetal aneuploidy by sequencing
EP2607496B1 (en) 2008-12-23 2014-07-16 Illumina, Inc. Methods useful in nucleic acid sequencing protocols
JP2012514977A (en) 2009-01-13 2012-07-05 キージーン・エン・フェー New genome sequencing strategy
US20100323348A1 (en) 2009-01-31 2010-12-23 The Regents Of The University Of Colorado, A Body Corporate Methods and Compositions for Using Error-Detecting and/or Error-Correcting Barcodes in Nucleic Acid Amplification Process
US9085798B2 (en) 2009-04-30 2015-07-21 Prognosys Biosciences, Inc. Nucleic acid constructs and methods of use
US20120165202A1 (en) 2009-04-30 2012-06-28 Good Start Genetics, Inc. Methods and compositions for evaluating genetic markers
US20130143747A1 (en) 2011-12-05 2013-06-06 Myriad Genetics, Incorporated Methods of detecting cancer
US9524369B2 (en) 2009-06-15 2016-12-20 Complete Genomics, Inc. Processing and analysis of complex nucleic acid sequence data
KR20120044941A (en) 2009-06-25 2012-05-08 프레드 헛친슨 켄서 리서치 센터 Method of measuring adaptive immunity
EP2456885A2 (en) 2009-07-20 2012-05-30 Bar Harbor Biotechnology, Inc. Methods for assessing disease risk
EP2494065B1 (en) 2009-10-26 2015-12-23 Lifecodexx AG Means and methods for non-invasive diagnosis of chromosomal aneuploidy
CN102597272A (en) 2009-11-12 2012-07-18 艾索特里克斯遗传实验室有限责任公司 Copy number analysis of genetic locus
US20110237444A1 (en) 2009-11-20 2011-09-29 Life Technologies Corporation Methods of mapping genomic methylation patterns
US9023769B2 (en) 2009-11-30 2015-05-05 Complete Genomics, Inc. cDNA library for nucleic acid sequencing
US9752187B2 (en) 2009-12-11 2017-09-05 Nucleix Categorization of DNA samples
US8835358B2 (en) 2009-12-15 2014-09-16 Cellular Research, Inc. Digital counting of individual molecules by stochastic attachment of diverse labels
US9315857B2 (en) 2009-12-15 2016-04-19 Cellular Research, Inc. Digital counting of individual molecules by stochastic attachment of diverse label-tags
EP3088532B1 (en) 2009-12-22 2019-10-30 Sequenom, Inc. Processes and kits for identifying aneuploidy
US8965076B2 (en) 2010-01-13 2015-02-24 Illumina, Inc. Data processing system and methods
US20110177512A1 (en) 2010-01-19 2011-07-21 Predictive Biosciences, Inc. Method for assuring amplification of an abnormal nucleic acid in a sample
US20120100548A1 (en) * 2010-10-26 2012-04-26 Verinata Health, Inc. Method for determining copy number variations
US9260745B2 (en) 2010-01-19 2016-02-16 Verinata Health, Inc. Detecting and classifying copy number variation
GB2485644B (en) 2010-01-19 2012-11-21 Verinata Health Inc Improved identification of chromosomal aneuploidies using a normalising sequence
US20120010085A1 (en) 2010-01-19 2012-01-12 Rava Richard P Methods for determining fraction of fetal nucleic acids in maternal samples
US10388403B2 (en) 2010-01-19 2019-08-20 Verinata Health, Inc. Analyzing copy number variation in the detection of cancer
AU2011207544A1 (en) 2010-01-19 2012-09-06 Verinata Health, Inc. Identification of polymorphic sequences in mixtures of genomic DNA by whole genome sequencing
WO2011103236A2 (en) 2010-02-18 2011-08-25 The Johns Hopkins University Personalized tumor biomarkers
EP2547698B1 (en) 2010-03-14 2015-07-29 The Translational Genomics Research Institute Methods of determining susceptibility of tumors to tyrosine kinase inhibitors
CN101967517B (en) 2010-03-19 2012-11-07 黄乐群 Polymerase chain reaction (PCR)-free gene detection method
CA2796578C (en) 2010-04-16 2021-11-23 Chronix Biomedical Breast cancer associated circulating nucleic acid biomarkers
US9255291B2 (en) 2010-05-06 2016-02-09 Bioo Scientific Corporation Oligonucleotide ligation methods for improving data quality and throughput using massively parallel sequencing
US20140186827A1 (en) * 2010-05-14 2014-07-03 Fluidigm, Inc. Assays for the detection of genotype, mutations, and/or aneuploidy
US20190010543A1 (en) 2010-05-18 2019-01-10 Natera, Inc. Methods for simultaneous amplification of target loci
US10316362B2 (en) 2010-05-18 2019-06-11 Natera, Inc. Methods for simultaneous amplification of target loci
US20130143214A1 (en) 2010-06-04 2013-06-06 Chronix Biomedical Prostate cancer associated circulating nucleic acid biomarkers
DK2580351T3 (en) 2010-06-09 2018-11-26 Keygene Nv Combinatorial sequence barcodes for high-throughput screening
EP2400035A1 (en) 2010-06-28 2011-12-28 Technische Universität München Methods and compositions for diagnosing gastrointestinal stromal tumors
WO2012006291A2 (en) 2010-07-06 2012-01-12 Life Technologies Corporation Systems and methods to detect copy number variation
KR20130041961A (en) 2010-07-23 2013-04-25 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 Methods for detecting signatures of disease or conditions in bodily fluids
EP2599545B1 (en) 2010-07-29 2019-09-04 Toto Ltd. Photocatalyst coated body and photocatalyst coating liquid
EP2601609B1 (en) 2010-08-02 2017-05-17 Population Bio, Inc. Compositions and methods for discovery of causative mutations in genetic disorders
US20120034603A1 (en) 2010-08-06 2012-02-09 Tandem Diagnostics, Inc. Ligation-based detection of genetic variants
US11031095B2 (en) * 2010-08-06 2021-06-08 Ariosa Diagnostics, Inc. Assay systems for determination of fetal copy number variation
EP2426217A1 (en) 2010-09-03 2012-03-07 Centre National de la Recherche Scientifique (CNRS) Analytical methods for cell free nucleic acids and applications
AU2011299088B2 (en) 2010-09-09 2015-12-24 Traxxsson, Llc Combination methods of diagnosing cancer in a patient
EP2619327B1 (en) 2010-09-21 2014-10-22 Population Genetics Technologies LTD. Increasing confidence of allele calls with molecular counting
RU2565550C2 (en) 2010-09-24 2015-10-20 Те Борд Оф Трастиз Оф Те Лилэнд Стэнфорд Джуниор Юниверсити Direct capture, amplification and sequencing of target dna using immobilised primers
WO2012042374A2 (en) † 2010-10-01 2012-04-05 Anssi Jussi Nikolai Taipale Method of determining number or concentration of molecules
WO2012048341A1 (en) 2010-10-08 2012-04-12 President And Fellows Of Harvard College High-throughput single cell barcoding
US8725422B2 (en) 2010-10-13 2014-05-13 Complete Genomics, Inc. Methods for estimating genome-wide copy number variations
SI2630263T2 (en) 2010-10-22 2022-04-29 Cold Spring Harbor Laboratory Varietal counting of nucleic acids for obtaining genomic copy number information
WO2012066451A1 (en) 2010-11-15 2012-05-24 Pfizer Inc. Prognostic and predictive gene signature for colon cancer
CN114678128A (en) 2010-11-30 2022-06-28 香港中文大学 Detection of genetic or molecular aberrations associated with cancer
RU2620959C2 (en) 2010-12-22 2017-05-30 Натера, Инк. Methods of noninvasive prenatal paternity determination
CN103384725A (en) * 2010-12-23 2013-11-06 塞昆纳姆股份有限公司 Fetal genetic variation detection
US9163281B2 (en) 2010-12-23 2015-10-20 Good Start Genetics, Inc. Methods for maintaining the integrity and identification of a nucleic acid template in a multiplex sequencing reaction
KR20210131432A (en) 2010-12-30 2021-11-02 파운데이션 메디신 인코포레이티드 Optimization of multigene analysis of tumor samples
US20140011694A1 (en) 2011-01-11 2014-01-09 Via Genomes, Inc. Methods, systems, databases, kits and arrays for screening for and predicting the risk of an identifying the presence of tumors and cancers
WO2012103031A2 (en) 2011-01-25 2012-08-02 Ariosa Diagnostics, Inc. Detection of genetic abnormalities
US20140024539A1 (en) 2011-02-02 2014-01-23 Translational Genomics Research Institute Biomarkers and methods of use thereof
CA2824387C (en) 2011-02-09 2019-09-24 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US20120238464A1 (en) 2011-03-18 2012-09-20 Baylor Research Institute Biomarkers for Predicting the Recurrence of Colorectal Cancer Metastasis
WO2012129363A2 (en) 2011-03-24 2012-09-27 President And Fellows Of Harvard College Single cell nucleic acid detection and analysis
AU2012236200B2 (en) 2011-03-30 2015-05-14 Verinata Health, Inc. Method for verifying bioassay samples
US9411937B2 (en) 2011-04-15 2016-08-09 Verinata Health, Inc. Detecting and classifying copy number variation
DK3246416T3 (en) 2011-04-15 2024-09-02 Univ Johns Hopkins SECURE SEQUENCE SYSTEM
JP2014512826A (en) 2011-04-25 2014-05-29 バイオ−ラド ラボラトリーズ インコーポレイテッド Methods and compositions for nucleic acid analysis
US8697408B2 (en) 2011-05-06 2014-04-15 New England Biolabs, Inc. Ligation enhancement
WO2012162267A2 (en) 2011-05-20 2012-11-29 Fluidigm Corporation Nucleic acid encoding reactions
US9752176B2 (en) 2011-06-15 2017-09-05 Ginkgo Bioworks, Inc. Methods for preparative in vitro cloning
KR101454886B1 (en) 2011-08-01 2014-11-03 주식회사 셀레믹스 Method for synthesizing nucleic acid molecules
US10704164B2 (en) 2011-08-31 2020-07-07 Life Technologies Corporation Methods, systems, computer readable media, and kits for sample identification
US9834766B2 (en) 2011-09-02 2017-12-05 Atreca, Inc. DNA barcodes for multiplexed sequencing
US8712697B2 (en) 2011-09-07 2014-04-29 Ariosa Diagnostics, Inc. Determination of copy number variations using binomial probability calculations
US20130079241A1 (en) 2011-09-15 2013-03-28 Jianhua Luo Methods for Diagnosing Prostate Cancer and Predicting Prostate Cancer Relapse
US9367663B2 (en) 2011-10-06 2016-06-14 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
CA2850785C (en) 2011-10-06 2022-12-13 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
US10196681B2 (en) 2011-10-06 2019-02-05 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
US10424394B2 (en) 2011-10-06 2019-09-24 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
US20130102485A1 (en) 2011-10-19 2013-04-25 Inhan Lee Method of Determining a Diseased State in a Subject
NO3051026T3 (en) 2011-10-21 2018-07-28
EP2768985B1 (en) 2011-10-21 2019-03-20 Chronix Biomedical Colorectal cancer associated circulating nucleic acid biomarkers
US20130122499A1 (en) 2011-11-14 2013-05-16 Viomics, Inc. System and method of detecting local copy number variation in dna samples
US10214775B2 (en) 2011-12-07 2019-02-26 Chronix Biomedical Prostate cancer associated circulating nucleic acid biomarkers
CN104094120B (en) 2011-12-08 2017-04-26 凡弗3基因组有限公司 Double minichromosomes comprising MDM2 and methods thereof
CN104334739A (en) 2012-01-13 2015-02-04 Data生物有限公司 Genotyping by Next Generation Sequencing
HUE053360T2 (en) 2012-02-17 2021-06-28 Hutchinson Fred Cancer Res Compositions and methods for accurate identification of mutations
US11177020B2 (en) 2012-02-27 2021-11-16 The University Of North Carolina At Chapel Hill Methods and uses for molecular tags
AU2013226081B2 (en) 2012-02-27 2018-06-14 Becton, Dickinson And Company Compositions and kits for molecular counting
US9670529B2 (en) 2012-02-28 2017-06-06 Population Genetics Technologies Ltd. Method for attaching a counter sequence to a nucleic acid sample
WO2013130791A1 (en) 2012-02-29 2013-09-06 Dana-Farber Cancer Institute, Inc. Compositions, kits, and methods for the identification, assessment, prevention, and therapy of cancer
US9892230B2 (en) 2012-03-08 2018-02-13 The Chinese University Of Hong Kong Size-based analysis of fetal or tumor DNA fraction in plasma
CA2867293C (en) 2012-03-13 2020-09-01 Abhijit Ajit PATEL Measurement of nucleic acid variants using highly-multiplexed error-suppressed deep sequencing
DK2828218T3 (en) 2012-03-20 2020-11-02 Univ Washington Through Its Center For Commercialization METHODS OF LOWERING THE ERROR RATE OF MASSIVELY PARALLEL DNA SEQUENCING USING DUPLEX CONSENSUS SEQUENCING
WO2013142213A1 (en) 2012-03-20 2013-09-26 Wake Forest University Health Sciences Methods, systems, and computer readable media for tracking and verifying receipt of contents of a delivery within an organization
WO2013148496A1 (en) 2012-03-26 2013-10-03 The Johns Hopkins University Rapid aneuploidy detection
US8209130B1 (en) * 2012-04-04 2012-06-26 Good Start Genetics, Inc. Sequence assembly
CA3209140A1 (en) 2012-04-19 2013-10-24 The Medical College Of Wisconsin, Inc. Highly sensitive surveillance using detection of cell free dna
PT2850211T (en) 2012-05-14 2021-11-29 Irepertoire Inc Method for increasing accuracy in quantitative detection of polynucleotides
AU2013267609C1 (en) 2012-05-31 2019-01-03 Board Of Regents, The University Of Texas System Method for accurate sequencing of DNA
CN104520443A (en) 2012-06-11 2015-04-15 赛昆塔公司 Method of sequence determination using sequence tags
US11261494B2 (en) 2012-06-21 2022-03-01 The Chinese University Of Hong Kong Method of measuring a fractional concentration of tumor DNA
WO2014004726A1 (en) 2012-06-26 2014-01-03 Caifu Chen Methods, compositions and kits for the diagnosis, prognosis and monitoring of cancer
EP2875149B1 (en) 2012-07-20 2019-12-04 Verinata Health, Inc. Detecting and classifying copy number variation in a cancer genome
DK2893040T5 (en) 2012-09-04 2019-03-18 Guardant Health Inc METHODS TO DETECT RARE MUTATIONS AND CAPITAL VARIATION
US10876152B2 (en) 2012-09-04 2020-12-29 Guardant Health, Inc. Systems and methods to detect rare mutations and copy number variation
US20140066317A1 (en) 2012-09-04 2014-03-06 Guardant Health, Inc. Systems and methods to detect rare mutations and copy number variation
US20160040229A1 (en) 2013-08-16 2016-02-11 Guardant Health, Inc. Systems and methods to detect rare mutations and copy number variation
WO2014093330A1 (en) 2012-12-10 2014-06-19 Clearfork Bioscience, Inc. Methods for targeted genomic analysis
AU2014204058A1 (en) 2013-01-05 2015-07-23 Foundation Medicine, Inc. System and method for outcome tracking and analysis
WO2014113729A2 (en) 2013-01-18 2014-07-24 Foundation Mecicine, Inc. Methods of treating cholangiocarcinoma
US20160034638A1 (en) 2013-03-14 2016-02-04 University Of Rochester System and Method for Detecting Population Variation from Nucleic Acid Sequencing Data
US9890425B2 (en) 2013-03-15 2018-02-13 Abbott Molecular Inc. Systems and methods for detection of genomic copy number changes
ES2980689T3 (en) * 2013-03-15 2024-10-02 Guardant Health Inc Methods for cell-free polynucleotide sequencing
US9816088B2 (en) * 2013-03-15 2017-11-14 Abvitro Llc Single cell bar-coding for antibody discovery
EP2971097B1 (en) 2013-03-15 2018-08-01 Verinata Health, Inc Generating cell-free dna libraries directly from blood
WO2014151117A1 (en) 2013-03-15 2014-09-25 The Board Of Trustees Of The Leland Stanford Junior University Identification and use of circulating nucleic acid tumor markers
WO2014148557A1 (en) 2013-03-19 2014-09-25 凸版印刷株式会社 Method for predicting sensitivity to egfr inhibitor
US10059989B2 (en) 2013-05-23 2018-08-28 The Board Of Trustees Of The Leland Stanford Junior University Transposition of native chromatin for personal epigenomics
JP6525473B2 (en) 2013-11-13 2019-06-05 ニューゲン テクノロジーズ， インコーポレイテッド Compositions and methods for identifying replicate sequencing leads
JP2015096049A (en) 2013-11-15 2015-05-21 凸版印刷株式会社 Method for predicting long-term efficacy of VEGF inhibitor
EP3524694B1 (en) 2013-12-28 2020-07-15 Guardant Health, Inc. Methods and systems for detecting genetic variants
PL4026917T3 (en) 2014-04-14 2024-04-08 Yissum Research And Development Company Of The Hebrew University Of Jerusalem Ltd. A method and kit for determining the death of cells or tissue or the tissue or cell origin of dna by dna methylation analysis
JP6659575B2 (en) 2014-04-21 2020-03-04 ナテラ， インコーポレイテッド Mutation detection and chromosomal segment ploidy
ES2844229T3 (en) 2014-05-13 2021-07-21 Univ Texas Gene mutations and copy number alterations of EGFR, KRAS, and MET
CN105296606B (en) 2014-07-25 2019-08-09 深圳华大基因股份有限公司 Method, device and use for determining free nucleic acid ratio in biological sample
KR102696857B1 (en) 2014-07-25 2024-08-19 유니버시티 오브 워싱톤 Methods of determining tissues and/or cell types giving rise to cell-free dna, and methods of identifying a disease or disorder using same
US20160053301A1 (en) 2014-08-22 2016-02-25 Clearfork Bioscience, Inc. Methods for quantitative genetic analysis of cell free dna
EP3192047A4 (en) 2014-09-10 2018-03-28 Pathway Genomics Corporation Health and wellness management methods and systems useful for the practice thereof
CN107075730A (en) 2014-09-12 2017-08-18 利兰·斯坦福青年大学托管委员会 Identification and Use of Circulating Nucleic Acids
CN107771221B (en) 2015-02-10 2021-11-02 香港中文大学 Mutation Detection for Cancer Screening and Fetal Analysis
US10844428B2 (en) 2015-04-28 2020-11-24 Illumina, Inc. Error suppression in sequenced DNA fragments using redundant reads with unique molecular indices (UMIS)
CA3006792A1 (en) 2015-12-08 2017-06-15 Twinstrand Biosciences, Inc. Improved adapters, methods, and compositions for duplex sequencing
ES3019936T3 (en) 2016-03-22 2025-05-21 Myriad Womens Health Inc Combinatorial dna screening
WO2017181146A1 (en) 2016-04-14 2017-10-19 Guardant Health, Inc. Methods for early detection of cancer

Also Published As

Publication number Publication date
DE202013012824U1 (en) 2020-03-10
JP6275145B2 (en) 2018-02-07
GB201509071D0 (en) 2015-07-08
US20210355549A1 (en) 2021-11-18
KR20210013317A (en) 2021-02-03
US10995376B1 (en) 2021-05-04
EP3470533B1 (en) 2019-11-06
HK1201080A1 (en) 2015-08-21
JP6664025B2 (en) 2020-03-13
JP2022169566A (en) 2022-11-09
EP4036247A1 (en) 2022-08-03
US10961592B2 (en) 2021-03-30
IL269097B2 (en) 2024-01-01
US20220205051A1 (en) 2022-06-30
GB2533006B (en) 2017-06-07
EP3842551C0 (en) 2023-11-01
US11001899B1 (en) 2021-05-11
JP7119014B2 (en) 2022-08-16
BR112015004847A2 (en) 2020-04-22
PT2893040T (en) 2019-04-01
IL269097A (en) 2019-11-28
US11773453B2 (en) 2023-10-03
US20200299785A1 (en) 2020-09-24
US20150368708A1 (en) 2015-12-24
EP2893040A1 (en) 2015-07-15
HK1225416B (en) 2017-09-08
US20220042104A1 (en) 2022-02-10
US20210130912A1 (en) 2021-05-06
US20230151435A1 (en) 2023-05-18
US20190185941A1 (en) 2019-06-20
US11319598B2 (en) 2022-05-03
US20200087736A1 (en) 2020-03-19
EP3470533B2 (en) 2023-01-18
KR20190112843A (en) 2019-10-07
US12049673B2 (en) 2024-07-30
US10793916B2 (en) 2020-10-06
CA2883901C (en) 2023-04-11
CA2883901A1 (en) 2014-03-13
US9834822B2 (en) 2017-12-05
ES2968333T3 (en) 2024-05-09
ES2711635T3 (en) 2019-05-06
US20190177802A1 (en) 2019-06-13
US12054783B2 (en) 2024-08-06
US12110560B2 (en) 2024-10-08
WO2014039556A1 (en) 2014-03-13
EP3842551A1 (en) 2021-06-30
US20240240258A1 (en) 2024-07-18
MX367963B (en) 2019-09-11
US20250051858A1 (en) 2025-02-13
MX2015002769A (en) 2015-08-14
GB2533006A (en) 2016-06-08
KR102210852B1 (en) 2021-02-01
US20200248270A1 (en) 2020-08-06
US20180223374A1 (en) 2018-08-09
US10947600B2 (en) 2021-03-16
US10494678B2 (en) 2019-12-03
US10041127B2 (en) 2018-08-07
US10822663B2 (en) 2020-11-03
US11319597B2 (en) 2022-05-03
ES2769241T3 (en) 2020-06-25
US20170218459A1 (en) 2017-08-03
JP2025016591A (en) 2025-02-04
JP2020103298A (en) 2020-07-09
US10876171B2 (en) 2020-12-29
EP2893040B1 (en) 2019-01-02
EP2893040A4 (en) 2016-04-27
US12319972B2 (en) 2025-06-03
US20200291487A1 (en) 2020-09-17
KR20150067161A (en) 2015-06-17
US12252749B2 (en) 2025-03-18
EP3591073A1 (en) 2020-01-08
US9598731B2 (en) 2017-03-21
US10876172B2 (en) 2020-12-29
US20250223656A1 (en) 2025-07-10
US20200087735A1 (en) 2020-03-19
US10457995B2 (en) 2019-10-29
EP3470533A1 (en) 2019-04-17
JP2020000237A (en) 2020-01-09
US20210032707A1 (en) 2021-02-04
ES2984550T3 (en) 2024-10-29
US20190185940A1 (en) 2019-06-20
DK2893040T5 (en) 2019-03-18
KR102393608B1 (en) 2022-05-03
IL237480A0 (en) 2015-04-30
IL269097B1 (en) 2023-09-01
US20190177803A1 (en) 2019-06-13
US10501810B2 (en) 2019-12-10
EP4424826A2 (en) 2024-09-04
PL3591073T3 (en) 2022-03-28
US20230323477A1 (en) 2023-10-12
US11879158B2 (en) 2024-01-23
US20180327862A1 (en) 2018-11-15
CN110872617A (en) 2020-03-10
US20170218460A1 (en) 2017-08-03
ES2906714T3 (en) 2022-04-20
EP4424826A3 (en) 2024-11-27
US10501808B2 (en) 2019-12-10
CN104781421A (en) 2015-07-15
JP2018027096A (en) 2018-02-22
KR20240007774A (en) 2024-01-16
HK1212396A1 (en) 2016-06-10
EP3591073B1 (en) 2021-12-01
KR102028375B1 (en) 2019-10-04
US20240200150A1 (en) 2024-06-20
IL237480B (en) 2019-10-31
ES2769241T5 (en) 2023-05-30
US20180171415A1 (en) 2018-06-21
US9840743B2 (en) 2017-12-12
US10837063B2 (en) 2020-11-17
US10683556B2 (en) 2020-06-16
US20210139998A1 (en) 2021-05-13
CN104781421B (en) 2020-06-05
US20150299812A1 (en) 2015-10-22
US20210340632A1 (en) 2021-11-04
JP2015535681A (en) 2015-12-17
SG11201501662TA (en) 2015-05-28
CA3190199A1 (en) 2014-03-13
PL2893040T3 (en) 2019-05-31
US10738364B2 (en) 2020-08-11
IL305303A (en) 2023-10-01
KR20220061271A (en) 2022-05-12
EP3842551B1 (en) 2023-11-01
EP4036247B1 (en) 2024-04-10
DK2893040T3 (en) 2019-03-11

Similar Documents

Publication Publication Date Title
IL269097B1 (en) Systems and methods to detect rare mutations and copy number variation
GB2528205B (en) Systems and methods to detect rare mutations and copy number variation
GB2523013B (en) Method and system to detect and select best photographs
EP2845080A4 (en) Object detection in touch systems
EP2845081A4 (en) Object detection in touch systems
IL235866A0 (en) Threat detection system and method
GB2509400B (en) Rigid-stem lead-in-method and system
SG11201406250SA (en) Method and system for detecting copy number variation
EP2591433A4 (en) Systems and methods to detect copy number variation
GB201322442D0 (en) Object detection methods display methods and apparatuses
EP2971139A4 (en) Systems and methods for detection of genomic copy number changes
EP2836923A4 (en) Methods and apparatus to copy and insert information
SG2013082912A (en) Purification arrangements and methods for gaspipeline systems
GB2506273B (en) Methods and systems for creating structural documents
HUE036039T2 (en) Neutron detection unit and neutron detection arrangement
EP2872985A4 (en) Advanced database systems and methods
IL238317B (en) Pipeline systems and methods
EP2893481A4 (en) Systems and methods for detecting illegitimate applications
SG2013082938A (en) Purification arrangements and methods for gaspipeline systems
SG11201404729SA (en) Systems and methods for file processing
HUE042608T2 (en) Detection system
GB201208761D0 (en) Computer-implemented reporting system and method
GB2510479B (en) Touch system and method
SG11201402925WA (en) Systems and methods for security detection
SG2013082920A (en) Purification arrangements and methods for gaspipeline systems